Boosting patient enrolment and retention in clinical trials: Expert Insights & Tips

Hosted by

• Guest speaker
  BN G
  Bas Nieuwenhuis Project Director​ Project Management @ Julius Clinical

• Guest speaker
  RG G
  Rick Grobbee Founder and Chief Scientific Officer @ Julius Clinical

  Prof Rick Grobbee, MD, Phd. Distinguished University Professor, Utrecht University, Founder and Chief Scientific Officer, Julius Clinical. Rick is a widely published expert in epidemiology and Real-World Evidence, and has also been a PI in many large-scale epidemiologic studies and randomized intervention trials relating to the prevention and treatment of cardiovascular, cardiometabolic, and cardiorenal disease. He will share insights from an epidemiological and Real-World Evidence perspective.

• Team member
  T
  Lieza Exalto Scientific Officer Neurology @ Julius Clinical

• Guest speaker
  Ld G
  Larah de Groot Project Director at Julius Clinical

  Larah de Groot, Project Director at Julius Clinical. Larah has almost 20 years experience in the clinical research industry and has managed global phase III trials in a range of indications. She will share practical considerations on this topic, drawing from recent studies where recruitment milestones were met ahead of time.

• Guest speaker
  SA G
  Steve Asche Vice President, Clinical Operation

  Steve Asche is the Senior Vice President of Clinical Operations at Julius Clinical, where he has spent the past seven years leading clinical and biometrics strategy and execution. With deep experience in both CRO and sponsor settings, Steve is known for building strong client relationships, driving operational efficiency, and overseeing successful delivery of global clinical trials. His leadership spans clinical operations, project management, site monitoring, feasibility, vendor oversight, and resource allocation. Steve also plays a vital role in business development and client governance, contributing to Peachtree’s growth and reputation for excellence. Previously, Steve held leadership roles at IQVIA, Syneos Health, and UCB Pharma, managing large-scale trials and spearheading quality initiatives. He holds a B.S. in Biology from Virginia Tech and is recognized for his mentorship, strategic vision, and industry expertise.